EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis

Sarfaraz K Niazi iD, Zamara Mariam iD

Pharmaceuticals · 22.12.2023 · 17 (1) · 22

DOI: 10.3390/ph17010022 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 22.12.2023. Verfasst von Sarfaraz K Niazi und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60012, USA. Die Arbeit wurde bisher 333-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the dynamic landscape of drug discovery, Computer-Aided Drug Design (CADD) emerges as a transformative force, bridging the realms of biology and technology. This paper overviews CADDs historical evolution, categorization into structure-based and ligand-based approaches, and its crucial role in rationalizing and expediting drug discovery. As CADD advances, incorporating diverse biological data and ensuring data privacy become paramount. Challenges persist, demanding the optimization of algorithms and robust ethical frameworks. Integrating Machine Learning and Artificial Intelligence amplifies CADDs predictive capabilities, yet ethical considerations and scalability challenges linger. Collaborative efforts and global initiatives, exemplified by platforms like Open-Source Malaria, underscore the democratization of drug discovery. The convergence of CADD with personalized medicine offers tailored therapeutic solutions, though ethical dilemmas and accessibility concerns must be navigated. Emerging technologies like quantum computing, immersive technologies, and green chemistry promise to redefine the future of CADD. The trajectory of CADD, marked by rapid advancements, anticipates challenges in ensuring accuracy, addressing biases in AI, and incorporating sustainability metrics. This paper concludes by highlighting the need for proactive measures in navigating the ethical, technological, and educational frontiers of CADD to shape a healthier, brighter future in drug discovery.

Schlagwörter

Stichwörter der Autor:innen

ChemoinformaticsComputer-Aided Drug Design (CADD)Machine Learning and Artificial Intelligence (AI)drug discoverymolecular dockingmolecular modelingtarget identification

Autor:innen und Institutionen

  • College of Pharmacy, University of Illinois, Chicago, IL 60012, USA.
  • Centre for Health and Life Sciences, Coventry University, Coventry City CV1 5FB, UK.

ORCID-Profile: Sarfaraz K Niazi, Zamara Mariam

Zitieren

APA

Niazi, S. K., & Mariam, Z. (2023). Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals, 17(1), 22. https://doi.org/10.3390/ph17010022

Vancouver

Niazi SK, Mariam Z. Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis. Pharmaceuticals. 2023;17(1):22. doi:10.3390/ph17010022

BibTeX
@article{Niazi2023,
  author = {Niazi, Sarfaraz K and Mariam, Zamara},
  title = {Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {17},
  number = {1},
  pages = {22},
  doi = {10.3390/ph17010022}
}
Kostenlos starten →